Biogen (BIIB) option IV into November 29 event

Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 31, December weekly is at 58, December is at 45; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Lincoln National (LNC) call put ratio 11.9 calls to 1 put with a focus on July 40 calls
• Apogee Therapeutics (APGE) call put ratio 1.1 calls to 1 put into share price up before the bell